Itinai.com biomedical laboratory close up still scene close u e4996bf4 1113 41b3 8fdd 0d1e6c918068 1
Itinai.com biomedical laboratory close up still scene close u e4996bf4 1113 41b3 8fdd 0d1e6c918068 1

Health economic evaluation alongside randomised clinical trial of a health behaviour intervention to manage type 2 diabetes in Nepal

Health Economic Evaluation of a Diabetes Intervention in Nepal

Background

Type 2 diabetes prevention is a major health issue in low and middle-income countries like Nepal. This study looked into the cost-effectiveness of a health behaviour intervention compared to regular care for managing diabetes in a community setting.

Methods

We randomly assigned 30 groups of patients with type 2 diabetes (481 patients total) to either a health behaviour intervention (238 patients) or usual care (243 patients). The intervention group received:

  • Intensive training for diabetes self-management led by community health workers.
  • Regular phone calls and ongoing support from peer supporters.

After 6 months, we assessed costs, quality-adjusted life years (QALYs), and the incremental cost-effectiveness ratio (ICER) from a healthcare system perspective. We used 10,000 simulations to analyze the cost-effectiveness under Nepal’s GDP threshold.

Results

Over 6 months, the intervention had:

  • An incremental cost of US $28.55 per person.
  • An incremental QALY of 0.0085 per person.
  • An ICER of US $3,358.82 per QALY gained, which is below the threshold, indicating it is cost-effective.
  • A net monetary benefit of US $6.64 per person.

The analysis showed an 89.63% probability that the intervention is cost-effective at the given threshold.

Conclusions

Community-based health behaviour interventions are a cost-effective way to manage type 2 diabetes, providing good value for money. Further studies are needed to explore long-term effects in various low and middle-income countries.

Trial Registration

This trial is registered with the Australia and New Zealand Clinical Trial Registry (ACTRN12621000531819).

Clinical Trials and AI Integration

Clinical trials are essential for creating safe and effective treatments. Our AI-driven platform, DocSym, combines ICD-11 standards, clinical protocols, and research into one easy-to-use resource for clinicians.

Streamlining Healthcare Operations

In today’s healthcare landscape, efficiency is key. Our mobile apps assist with scheduling, treatment monitoring, and telemedicine, simplifying patient care management and expanding digital services.

Enhancing Clinic Workflows

By leveraging AI, clinics can improve workflows, patient outcomes, and reduce paperwork. Discover how we can help at aidevmd.com.

AI-Powered Health Tools

Interactive AI Tools to Help You Understand Your Health

Solutions for Smart Healthcare

Clinical Research